To compare the demographic characteristics and exposure to endogenous, exogenous estrogens and progestins between patients with Early-Onset Parkinson's Disease (EOPD), Late-Onset Parkinson's Disease (LOPD), and EOPD-matched unaffected controls.
No takes yet. Share an insight, caveat, or question.
Patanè et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: